Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells

Oncology Reports

Volumn 26, Issue 4, 2011, Pages 925-930

  Lin, Hong ^a   Xiong, Wei ^a   Zhang, Xiang ^a   Liu, Bolin ^a   Zhang, Wei ^a   Zhang, Yongqiang ^a   Cheng, Jinxiang ^a   Huang, Huiyong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Glioblastoma; Notch 1; p53; Resveratrol

Indexed keywords

CASPASE 3; NOTCH1 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENES, P53; GLIOBLASTOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; STILBENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79960815940     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1380     Document Type: Article

References (21)

1. Khasraw M and Lassman AB: Advances in the treatment of malignant gliomas. Curr Oncol Rep 12: 26-33, 2010.
2. Jahraus CD and Friedman AH: Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy. Tumori 96: 771-775, 2010.
3. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
4. Quant EC and Wen PY: Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials. Neuroimaging Clin N Am 20: 425-448, 2010.
5. Kanamori M, Kawaguchi T, Nigro JM, et al: Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106: 417-427, 2007. (Pubitemid 46354295)
6. Lino MM, Merlo A and Boulay JL: Notch signaling in glioblastoma: a developmental drug target? BMC Med 8: 72, 2010.
7. Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A and Lafuente JV: Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and Notch signaling pathways. J Mol Neurosci 32: 53-63, 2007. (Pubitemid 47450557)
8. Li JL, Sainson RC, Shi W, et al: Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67: 11244-11253, 2007. (Pubitemid 350248550)
9. Soussi T and Wiman KG: Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 12: 303-312, 2007. (Pubitemid 47539312)
10. Zhang WB, Wang Z, Shu F, et al: Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. J Biol Chem 285: 40461-40471, 2010.
11. Berger B, Capper D, Lemke D, et al: Defective p53 antiangiogenic signaling in glioblastoma. Neuro Oncol 12: 894-907, 2010.
12. Schneider JG, Alosi JA, McDonald DE and McFadden DW: Pterostilbene inhibits lung cancer through induction of apoptosis. J Surg Res 161: 18-22, 2010.
13. He X, Wang Y, Zhu J, Orloff M and Eng C: Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling. Cancer Lett 301: 168-176, 2011.
14. Zhang W, Fei Z, Zhen HN, Zhang JN and Zhang X: Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J Neurooncol 81: 231-240, 2007. (Pubitemid 46165325)
15. Lin H, Zhang X, Cheng G, et al: Apoptosis induced by ardipusilloside III through BAD dephosphorylation and cleavage in human glioblastoma U251MG cells. Apoptosis 13: 247-257, 2008.
16. Lin H, Wang YG, Zhang X, Liu BL, Zhang W and Cheng JX: Prognostic significance of kappaB-Ras1 in gliomas. Med Oncol: Feb 8, 2011 (Epub ahead of print).
17. Truong M, Cook MR, Pinchot SN, Kunnimalaiyaan M and Chen H: Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Ann Surg Oncol 18: 1506-1511, 2011.
18. Pinchot SN, Jaskula-Sztul R, Ning L, et al: Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer 117: 1386-1398, 2011.
19. Cecchinato V, Chiaramonte R, Nizzardo M, et al: Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells. Biochem Pharmacol 74: 1568-1574, 2007. (Pubitemid 47614962)
20. Li J, Cui Y, Gao G, Zhao Z, Zhang H and Wang X: Notch1 is an independent prognostic factor for patients with glioma. J Surg Oncol: doi:10.1002/jso.21851, 2011.
21. Gilbert CA, Daou MC, Moser RP and Ross AH: Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 70: 6870-6879, 2010.